baber/WOPTO huggingface dataset:
Patent MX-2010000304-A (MX)
Title: Molded filter end cap and method of manufacture.
Inventor: SAVAGE JEFFREY
IPC: B01D46/24
Filed: 2008-07-02
Abstract: A filter element including a filter media, a first end cap, and a second end cap is provided. The filter media has first and second filter ends. The first end cap is attached to the first filter end and the second end cap is attached to the second filter end. The second end cap is formed from a molded material and includes a handle structure unitarily molded therein. The handle structure includes a flange with a void formed at least partially transversely therethrough. The void is molded without a mold split such that no mold split parting line is formed on the second end cap. In one embodiment, the void is formed in the flange of the handle structure using a grommet molded therein.
Patent MX-2010002151-A (MX)
Title: Conduit breach detection system.
Inventor: GUTIERREZ ALEJANDRO MANUEL
IPC: E21B43/17
Filed: 2010-02-24
Abstract: A conduit breach detection system is disclosed. The system comprises a conduit system defining an interstitial space and a control system. The control system includes multiple pressure sensors in communication with the interstitial space and a controller programmed to monitor pressure within the interstitial space, declare a breach in the conduit system when the pressure in the interstitial space changes, and locate a position of a breach. Other features and a method of detecting a breach in a conduit system are also disclosed.
Patent MX-2010003325-A (MX)
Title: Novel antibodies.
Inventor: YE WEILAN
IPC: A61P35/00
Filed: 2008-09-25
Abstract: The present invention relates to the use of VEGF antagonists and a novel anti-?5?1 antibody for treating cancer and inhibiting angiogenesis and/or vascular permability, including inhibiting abnormal angiogenesis in diseases. The present invention also relates to compositions and kits comprising novel anti-?5?1 antibodies and methods of making and using them.
Patent MX-2010004457-A (MX)
Title: Idarubicin for the treatment of lymphoma in a dog.
Inventor: BERLINSKI PAMELA JO
IPC: A61P35/00
Filed: 2008-10-15
Abstract: The present invention relates to a method of treating a lymphoma in a dog comprising administering to a dog in need of such treatment a therapeutically effective amount of idarubicin or a pharmaceutically acceptable salt thereof.
Patent MX-2010004911-A (MX)
Title: Acid cleaning method in the brewing industry.
Inventor: LAFFITTE JEAN-ALEX
IPC: C11D3/00
Filed: 2008-11-12
Abstract: The present invention relates to an acid cleaning method in the brewing industry, in particular an improved method for the acid cleaning of the various pieces of equipment used for manufacturing beer and other similar fermented beverages, by the use of a formulation comprising at least one alkanesulphonic acid.
Patent MX-2010006344-A (MX)
Title: Track for an adjustable blind assembly.
Inventor: FULTON DANIEL
IPC: E06B7/00
Filed: 2010-06-09
Abstract: A track for an adjustable blind assembly is disclosed. One described track for an adjustable blind assembly comprises a track comprising a base and a slot, the base comprising a flange portion and a brace portion, the flange portion extending from the base and securable to a spaced window pane by a window frame, and the slot extending from the base and comprising a channel for a sliding adjuster.
Patent MX-2010008285-A (MX)
Title: Galenic form for the oral transmucosal delivery of triptans.
Inventor: PEROVITCH PHILIPPE
IPC: A61K31/404
Filed: 2009-01-29
Abstract: The invention relates to a galenic form for the oral transmucosal delivery of at least one active ingredient of the family of triptans, comprising at least: said active ingredient in base form and in salt form, and an aqueous-alcoholic solution with a titer of at least 15 degrees alcohol, said active ingredient being present in a stable and complete dissolution state in the aqueous-alcoholic solution, for rapid absorption of said active ingredient through the mucosa of the oral cavity and/or of the oropharynx. The invention also relates to a method for obtaining this galenic formulation and to the use thereof.
Patent MX-2010008385-A (MX)
Title: Bubble shaped membrane and use of such membrane in a device.
Inventor: GYRN STEFFEN
IPC: A61M5/142
Filed: 2009-02-24
Abstract: The invention relates to a membrane (17) completely covering an opening (13) giving access to a space in a device which membrane (17) is made of an elastic material penetrable by a needle, the membrane (17) is fastened around the opening (13) and the membrane (17) protrudes from the opening (13) and forms an air filled volume in front of the opening (13) which air filled volume can be reduced in size when a pressure is put on the membrane (17) from the outside, the inner surfaces of the membrane (17) define a passage (17a) at the first closed end of the membrane (17) through which a needle (19) can pass and the second end of the membrane (17) is adapted to attach the membrane (17) to a holding part (61). The walls of the membrane (17) have a thickness and shape of the chosen membrane material making it possible, to maintain the protruding shape in a use position without the outer surfaces of the membrane (17) are supported with walls of rigid material. Also the invention relates to a device in which the membrane is used, and a kit where this device is combined with a corresponding unit.
Patent MX-2010008496-A (MX)
Title: Method for determination of sensitivity to anti-cancer agent.
Inventor: TANIGAWARA YUSUKE
IPC: A61K31/282
Filed: 2009-01-30
Abstract: Disclosed is a marker for determining the sensitivity to an anti-cancer agent, which can determine the therapeutic responsibility in individual patients. Also disclosed is a novel cancer treatment means utilizing the marker. Specifically disclosed is a marker for determining the sensitivity to an anti-cancer agent, which comprises a calcium-binding protein S100A7, S100A8 or S100A10.
Patent MX-2010010144-A (MX)
Title: Hemicellulase enriched compositions for enhancing hydrolysis of biomass.
Inventor: LANTZ SUZANNE E
IPC: C12N9/24
Filed: 2009-03-20
Abstract: Described are compositions and methods relating to cellulase/hemicellulase enzyme blends for improving the enzymatic hydrolysis of cellulosic and hemicellulosic materials, as commonly found in biomass.
Patent MX-2010010791-A (MX)
Title: Substituted 1,3-cyclopentadione attenuated endothelial inflammation and endothelial-monocyte interactions.
Inventor: VEERA KONDA
IPC: C07C49/00
Filed: 2009-04-02
Abstract: Compositions and methods for reducing cardiovascular risk utilizing substituted 1,3- cyclopentadione compounds are described.
Patent MX-2010011995-A (MX)
Title: Methods and kits for the treatment of inflammatory bowel disorder conditions.
Inventor: MAGOWAN SIMON HENRY
IPC: A61K35/745
Filed: 2009-04-30
Abstract: The present invention comprises methods and kits that are useful for the treatment an inflammatory bowel disease. The methods comprise administering to a mammal in need of treatment a composition comprising an active agent in combination with a probiotic and/or optionally an antibiotic.
Patent MX-2010013309-A (MX)
Title: Toner processes.
Inventor: VONG CUONG
IPC: A61K8/00
Filed: 2010-12-03
Abstract: The present disclosure provides toners and processes for making said toners. In embodiments, the toners are invisible when viewed under natural light, but possess a UV emitter that renders them visible when exposed to UV light of a specific wavelength. By selecting the appropriate UV emitter and utilizing an ionic crosslinker, the gloss of the toner may be tailored to match the gloss of any substrate, such as paper, to which the toner is to be applied, thereby further enhancing its invisibility under visible light.
Patent MX-2010013500-A (MX)
Title: A method and apparatus for pcc enhancement for flow based mobility.
Inventor: HAIPENG JIN
IPC: H04L12/28
Filed: 2009-06-09
Abstract: Systems and methods are described that facilitate multiple registrations and flow based mobility in a wireless communication network. A flow routing component can be included in a mobile device, home agent / p-gateway, or a policy and charging rules function server that determines the manner in which to route one or more IP flows through a set of network access entry points. The flow routing component can determine the routing based on a set of policies and/or network data, such as quality of service requirements, bandwidth requirements, network congestion, currently active IP flows, and so forth.
Patent MX-2010013714-A (MX)
Title: Maize product nixtamalized and fermented with probiotic lactic bacteria and the process for preparing the same.
Inventor: GONZALEZ GUSTAVO VINIEGRA
IPC: A23L1/00
Filed: 2010-12-13
Abstract: Process for preparing a product, and resulting product, which consist in a liquid or semisolid fermented maize porridge used as raw material in the formulation of different food. The process includes nine steps: cleaning, partial nixtamalization, first mill-sieve, cooking, second mill-sieve, formulation, inoculation, fermentation and cooling performed under specific conditions for obtaining a product with a suitable balance of soluble and resistant starches, a suitable content of unsaturated fatty acids and ion calcium, with a light nixtamal and acid flavour and a light dairy smell produced by an increased amount of viable, harmless, probiotic and amylolytic Lactobacillus acidophilus and Pediococcus pentosaceus strains. The product has probiotic, prebiotic and symbiotic properties according to the process and the used components.
Patent MX-2011000745-A (MX)
Title: Automated valve testing apparatus.
Inventor: WHEATER CHRISTOPHER JOHN
IPC: F16K37/00
Filed: 2008-07-25
Abstract: A method for partially stroking an emergency valve apparatus is provided. The emergency valve apparatus comprises an actuator (103) and a valve member (101). The apparatus is movable between a first position and a second position. The method comprises the step of initiating a partial stroke movement of the apparatus from the first position towards the second position. A parameter of the fluid acting on the apparatus is measured. Once the measured parameter reaches a threshold value, the partial stroke movement is reversed.
Patent MX-2011002602-A (MX)
Title: Combination of hcv ns3 protease inhibitor with interferon and ribavirin.
Inventor: HUANG DAVID
IPC: A61K45/06
Filed: 2009-09-14
Abstract: The present invention relates to therapeutic combinations comprising (a) Compound (1), or a pharmaceutically acceptable salt thereof, as herein described, (b) an interferon alfa and (c) ribavirin. Compound (1) is a selective and potent inhibitor of the HCV NS3 serine protease. The present invention also relates to methods of using such therapeutic combinations for treating HCV infection or alleviating one or more symptoms thereof in a patient.
Patent MX-2011004793-A (MX)
Title: Crystalline forms.
Inventor: BORDEAU KENNETH J
IPC: C07D487/04
Filed: 2009-12-03
Abstract: The invention is directed to crystalline forms of 2-[4-(7-ethyl-5H-pyrrolo[2,3-b]pyrazin-6-yl)-phenyl]-propan-2-o l, characterized by physico-chemical data described herein.
Patent MX-2011006438-A (MX)
Title: Techniques to manage and display related communications.
Inventor: VANKAMAMIDI SANDHYA
IPC: G06Q10/00
Filed: 2009-11-16
Abstract: Techniques to manage and display related communications are described. A system may comprise a communication management tool (CMT) operative on a computer, the CMT comprising a threading component operative to associate a plurality of communications from a plurality of communication types with a conversation thread, and a display component operative to display communications in a conversation thread as a conversation view. Other embodiments are described and claimed.
Patent MX-2011006725-A (MX)
Title: Combination of aurora kinase inhibitors and anti-cd20 antibodies.
Inventor: MANFREDI Mark
IPC: A61K31/4745
Filed: 2009-12-15
Abstract: The present invention relates to methods for the treatment of hematological malignancies. In particular, the invention provides methods for treatment of hematological malignancies by administering Aurora kinase inhibitors in combination with anti-CD20 antibodies.
Patent MX-2011006840-A (MX)
Title: Systems and methods for planning well locations with dynamic production criteria.
Inventor: CULLICK ALVIN STANLEY
IPC: G06F9/455
Filed: 2009-12-07
Abstract: Systems and methods for automatically and optimally planning multiple well locations within a reservoir simulator. The systems and methods use dynamic production criteria to create and optimize well target completion intervals and the associated well geometries for new wells dynamically, and directly within a reservoir simulator.
Patent MX-2011009977-A (MX)
Title: System and method for utilizing forward error correction with video compression.
Inventor: PERLMAN STEPHEN G
IPC: H04N19/89
Filed: 2010-03-17
Abstract: A computer-implemented system and method are described for performing video compression A method according to one embodiment comprises encoding a plurality of video frames or portions according to a first encoding format, transmitting the plurality of encoded video frames or portions to a client device, receiving feedback information from the client device, the feedback information usable to determine whether data contained in the video frames or portions has not been successfully received and/or decoded, in response to detecting that one or more video frames or portions thereof have not been successfully received and/or decoded, and applying FEC coding to selected frames or applying adaptive FEC coding to the frames and transmitting the new video frame or portion thereof to the client device.
Patent MX-2011011338-A (MX)
Title: Composition and methods of use for therapeutic antibodies specific for the il-12 receptore betal subunit.
Inventor: HERRERA JOSE M CARBALLIDO
IPC: C07K16/28
Filed: 2010-03-29
Abstract: The present invention relates to antibodies that specifically bind to IL12RÎ²1, the non-signal transducing chain of the heterodimeric IL12 receptor (together with IL12RÎ²2 chain) as well as IL23 receptor (together with IL23RÎ± chain). The invention more specifically relates to specific antibodies that are IL12 and IL23 receptor antagonists capable of inhibiting IL12/IL18 induced IFNy production of T cells and compositions and methods of use for said antibodies to treat pathological disorders that can be treated by inhibiting IFNy production, such as rheumatoid arthritis, psoriasis or inflammatory bowel diseases or other autoimmune and inflammatory disorders.
Patent MX-2011013720-A (MX)
Title: A method of forming a functional razor cartridge and a functional razor cartridge.
Inventor: PETERSON MARK
IPC: B29C67/00
Filed: 2010-06-17
Abstract: A method of forming a functional razor cartridge for repeated shaving comprises rapid prototyping a housing of a razor cartridge. The housing has a front wall, a rear wall and opposing side walls disposed transverse to and between said front and rear walls. The method further comprises loading a metal insert with one or more elongate blade assemblies and disposing the metal insert in the housing such that the one or more blade assemblies extend between the opposing side walls of the housing.
Patent MX-2011013792-A (MX)
Title: Controlled-rheology polypropylene.
Inventor: MALLEN MICHAEL P ZUM
IPC: C08F10/06
Filed: 2010-06-21
Abstract: Controlled rheology (CR) polypropylene resins are prepared by a process comprising the step of contacting under scission conditions a non-CR-polypropylene resin having a low melt flow rate (MFR) with cyclic peroxide. The CR polypropylene resins made by the process of this invention are useful in manufacturing articles that exhibit reduced VOC emissions relative to CR-polypropylene resins made by an identical process except with non- cyclic peroxide. These low-VOC, CR-polypropylene resins are particularly useful in making non-metallic components for automobile interiors.
Patent MX-2012001371-A (MX)
Title: Methods and systems for associating and providing media content of different types which share attributes.
Inventor: WOODS THOMAS STEVEN
IPC: H04N7/173
Filed: 2010-07-14
Abstract: Systems and methods are provided for associating and providing media content of different types which share attributes. When an audio asset is selected for playback, visual media content, which includes the audio asset, may be identified and associated with the audio asset. The realted visual media content may be displayed during playback of the audio asset to provide a compelling visual component during audio asset playback.
Patent MX-2012003397-A (MX)
Title: Wireline cable for use with downhole tractor assemblies.
Inventor: VARKEY JOSEPH
IPC: E21B23/14
Filed: 2010-09-22
Abstract: A wireline cable includes an electrically conductive cable core for transmitting electrical power, an inner armor layer disposed around the cable core, and an outer armor layer disposed around the inner armor layer, wherein a torque on the cable is balanced by providing the outer armor layer with a predetermined amount of coverage less than an entire circumference of the inner armor layer, or by providing the outer armor layer and the inner armor layer with a substantially zero lay angle.
Patent MX-2012005195-A (MX)
Title: Formulation for hgh and rhigf-1 combination.
Inventor: ARAKAWA TSUTOMU
IPC: A61K38/27
Filed: 2010-11-17
Abstract: The present invention relates to pharmaceutical compositions. More particularly, the invention relates to formulations of growth hormone (GH) and insulin-like growth factor (IGF-1 ) combination compositions which provide stable pharmaceutical compositions without aggregation formation at a desirable pH, and to processes of preparation thereof.
Patent MX-2012006604-A (MX)
Title: Parenteral pharmaceutical formulation in suspension, having sustained release, in low and ultralow dosage, in hormonal therapy in the climacteric syndrome.
Inventor: VILBOEUF JOHN CLAUDE SAVOIR
IPC: A61P5/34
Filed: 2010-12-14
Abstract: Parenteral pharmaceutical formulation or composition, in suspension, having sustained release, containing suspended particles of estradiol and progesterone for hormonal replacement in female mammals in low and ultralow dosage; the formulation consists of an injectable suspension comprising particles of estradiol, particles of progesterone, a surfactant agent, an isosmotic agent, a thickening agent, and one or more preservation agents, wherein the estradiol is in particles having a size between 1 and 100 microns and the progesterone is in particles having a size between 1 and 100 microns, for application thereof in parenteral, intramuscular, subcutaneous or intradermal pharmaceutical form.
Patent MX-2012009138-A (MX)
Title: Dispenser cap with selectable reservoirs.
Inventor: WORTHINGTON BRIAN GLENN
IPC: B65D83/14
Filed: 2011-02-24
Abstract: A dispensing cap (1) is disclosed for mixing a primary flowable substance, such as a soap, lotion, or the like, with a small dose of a secondary flowable substance, such as a fragrance. The dispensing cap includes a plurality of reservoirs (2a-c) containing a plurality of secondary flowable substances. Each of the reservoirs is associated with a secondary piston that, when actuated, causes the secondary flowable substance to be expelled from the reservoir into a mixing chamber (4) in the cap, where it is mixed with the primary flowable substance. Upon mixing the two are dispensed together from a dispensing end of the cap. A selector ring (36) is provided to enable the user to select one of the plurality of reservoirs. The selector ring has an actuation flange that aligns with the secondary piston that is associated with the selected reservoir.
Patent MX-2012010569-A (MX)
Title: System, method and interface display for verifying and managing distribution and sales of medicine.
Inventor: SANGAL PUNEET M
IPC: G16H20/10
Filed: 2010-12-21
Abstract: A system, method and graphical user interface display for validating, monitoring and otherwise reviewing the sales and distribution of medicines, to reduce the instances of counterfeit medicines. A pharmaceutical company provides medicines to users, either directly or through representatives for the pharmaceutical company. The products have associated identifying codes that are used to track the sales of the products. The system provides verifications of the medicines, as well as statistical analysis of the sales and distribution. The verifications and comparisons of the distribution and sales of the medicines can be reviewed by the user or on a dashboard user interface. The system further allows pharmaceutical companies provided the medicines to provide response messages to users.
Patent MX-2012012569-A (MX)
Title: Laminar photobioreactor for the production of microalgae.
Inventor: GONZALEZ JESUS FERNANDEZ
IPC: C12M3/00
Filed: 2011-04-07
Abstract: The invention relates to a modular photobioreactor for the production of microalgae, intended in particular for absorbing emission gases with a high carbon dioxide (CO2) content. The invention is based on: the continuous recirculation of a microalgae-containing liquid medium through sheets of fabric that facilitate CO2 absorption, and the illumination of the microalgae. The invention allows the aforementioned gases to be added to the culture from inside the chamber. The invention is advantageous in that it provides highly efficient algae illumination, facilitates the exchange of CO2 from the emission gases to the culture, and can be used at a low cost on a large scale.
Patent MX-2012013570-A (MX)
Title: System for controlling the speed in induction engines using artificial intelligence.
Inventor: FIGUEROA FERNANDO DAVID RAMÍREZ
IPC: G05B13/02
Filed: 2012-11-22
Abstract: The invention pertains to the technological design area, especially to the design of an intelligent system for controlling the speed in induction engines using a direct control of the pair and techniques of artificial intelligence based on fuzzy logic, evolutionary programming and fuzzy clustering. A fuzzy PID controller was designed and implemented, which is optimized offline using genetic programming techniques. In addition, the form of the membership functions is adjusted online by a Fuzzy clustering algorithm (FCM) with the purpose of improving the response of the controller without introducing an excessive computer load.
Patent MX-2012013894-A (MX)
Title: Separator for lead acid battery.
Inventor: BECKLEY GORDON C
IPC: H01M50/466
Filed: 2011-06-23
Abstract: Separators for lead-acid batteries, and lead-acid batteries including the same are provided. The separator includes a first layer made of a rubber material and a second layer made of a polymer material.
Patent MX-2012014540-A (MX)
Title: Toner compositions of biodegradable amorphous polyester resins.
Inventor: SACRIPANTE GUERINO G
IPC: G03G9/16
Filed: 2012-12-13
Abstract: Disclosed is a toner that includes a mixture of a bio-based amorphous polyester resin, a crystalline polyester resin, and a colorant.
Patent MX-2013002551-A (MX)
Title: Method for manufacturing reductive stone material using molten slag.
Inventor: WANG QINGTAO
IPC: C04B5/06
Filed: 2011-09-20
Abstract: A method for manufacturing a reductive stone material using a molten slag. The method comprises these steps: controlling the molten slag at a temperature between 1,400Â°C and 1,500Â°C, and cast molding at a controlled temperature; thermally insulating the molded molten slag at a temperature between 800Â°C and 1,000Â°C in a non-reductive atmosphere for one to five hours, and then cooling gradually to room temperature within two to five hours to acquire the reductive stone material. The method provides an energy conserving and high efficiency way of utilizing blast furnace slag. The reductive stone material produced is characterized by color stability, wear resistance, pressure resistance, non-flakiness, a low expansion coefficient, and a low contractability rate.